top of page
BETA-2 Calculated Based on Single Fasting Blood Sample Allows to Define and Discriminate between Optimal and Suboptimal Islet Allograft Function Prior to the Clinical Need for Insulin Support.
Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study
Validation of a new North American Islet Donor Score for donor pancreas selection and successful islet isolation in a medium volume islet transplant center.
bottom of page